Condition: Acute Coronary Syndromes (ACS) · Iron Deficiencies · Elderly (People Aged 65 or More) · Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia
The goal of this phase IV, open-label, randomized clinical trial is to evaluate whether intravenous iron improves quality of life in adults aged 65 years and older with iron deficiency after an acute coronary syndrome (ACS). The main questions it aims to answer are: * Does intravenous iron improve quality of life at 6 and 12 months? * Does it reduce frailty and adverse clinical outcomes? Researchers will compare intravenous ferric carboxymaltose with standard of care. Participants will: * Be randomly assigned to receive intravenous iron or standard care * Attend three study visits over 12 months * Complete questionnaires and undergo blood tests
This description comes directly from the study's public registry record.
Clara Bonanad Lozano, Doctor · +34 686 10 70 71 · clarabonanad@gmail.com
Claudio Rivadulla Varela, Doctor · +34 625 11 46 86 · c.rivare@hotmail.com
Always discuss trial participation with your own doctor first.
| Hospital Clínico Universitario Virgen de la Arrixaca | El Palmar, Murcia, Spain | Recruiting |
| Hospital Álvaro Cunqueiro | Vigo, Pontevedra, Spain | Not Yet Recruiting |
| Hospital Universitario de Badajoz | Badajoz, Spain | Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Spain | Not Yet Recruiting |
| Hospital Universitario Clínico San Cecilio | Granada, Spain | Recruiting |
| Hospital Universitario de León | León, Spain | Not Yet Recruiting |
| Hospital Clínico San Carlos | Madrid, Spain | Recruiting |
| Hospital Universitario de Navarra | Pamplona, Spain | Not Yet Recruiting |
| Hospital Clínico Universitario de Valencia | Valencia, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07476859